Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Presentation TCT 2025

From Anatomy to Outcome: Optimizing Device Selection in Transcatheter Tricuspid Therapy

Presenter: Azeem Latib

October 28, 2025

Presentation TCT 2025

TCT 973: A Systematic Review and Meta-analysis of Intra-Aortic Balloon Pump compared with Medical Therapy alone or with Left-Ventricular Assist Device for Cardiogenic Shock

Presenter: Aleena Usman

October 27, 2025

Presentation TCT 2025

Patient-Specific Diagnostic, Monitoring & Predictive Devices for Structural Heart Healthcare (Prognics)

Presenter: Mohammad Sarraf

October 27, 2025

Presentation TCT 2025

Renal Denervation is FDA Approved - Will it Ever Be First Line Therapy?

Presenter: David P. Lee

October 27, 2025

Presentation TCT 2025

Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

Presenter: Josep Rodés-Cabau

October 26, 2025

Presentation TCT 2025

GLP-1 and GIP Antagonism on HF Therapy: Implications for Device Therapy

Presenter: Sheldon E. Litwin

October 25, 2025

Presentation TCT 2025

ARS 29: At the Crossroads of Medical and Device Therapy in HF Treatment

Presenter: Daniel Burkhoff

October 25, 2025

Presentation TCT 2025

TCT 1490: Concomitant Transcatheter Mitral Edge-to-Edge Repair and Left Ventricular Assist Device Therapy in Patients With Acute Decompensated Heart Failure or Cardiogenic Shock and Severe Mitral Regurgitation: A Case Series

Presenter: Michal Kosowski

October 25, 2025

Advertisement

From Anatomy to Outcome: Optimizing Device Selection in Transcatheter Tricuspid Therapy

TCT 973: A Systematic Review and Meta-analysis of Intra-Aortic Balloon Pump compared with Medical Therapy alone or with Left-Ventricular Assist Device for Cardiogenic Shock

Patient-Specific Diagnostic, Monitoring & Predictive Devices for Structural Heart Healthcare (Prognics)

Renal Denervation is FDA Approved - Will it Ever Be First Line Therapy?

Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

GLP-1 and GIP Antagonism on HF Therapy: Implications for Device Therapy

ARS 29: At the Crossroads of Medical and Device Therapy in HF Treatment

TCT 1490: Concomitant Transcatheter Mitral Edge-to-Edge Repair and Left Ventricular Assist Device Therapy in Patients With Acute Decompensated Heart Failure or Cardiogenic Shock and Severe Mitral Regurgitation: A Case Series

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content